Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/2012
07/10/2012CA2462564C Methods of inhibiting metastases
07/10/2012CA2446356C Use of compositions for treating rosacea
07/10/2012CA2444821C Combination therapy using anti-angiogenic agents and tnfa
07/10/2012CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents
07/10/2012CA2440010C Powder inhaler formulations
07/10/2012CA2435712C Universal carrier for targeting molecules to gb3 receptor expressing cells
07/10/2012CA2417960C Method of using diketopiperazines and composition containing them
07/10/2012CA2368677C Intramyocardial injection of autologous bone marrow
07/10/2012CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases
07/10/2012CA2340790C Human il-1 epsilon dna and polypeptides
07/10/2012CA2211324C Recombinant human alpha-fetoprotein and uses thereof
07/10/2012CA2210992C Mixture of fatty acids, derivatives and a compound of vegetal origin having attractive effect on cats
07/05/2012WO2012091571A2 Combination of components for the prevention and treatment of frailty
07/05/2012WO2012091115A1 Acetylene derivative and pharmaceutical application therefor
07/05/2012WO2012091081A1 Interferon production-inducing agent containing lactic acid bacteria
07/05/2012WO2012091010A1 Bicyclic pyrimidine derivative
07/05/2012WO2012090713A1 Concomitant drug for improving cognitive function
07/05/2012WO2012090676A1 Novel medicinal composition and utilization of same
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172378 Novel compounds
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120172333 Pyrrolo-pyridine derivatives as activators of ampk
07/05/2012US20120171309 Formulations and methods for increasing efficacies and improving flavors of formulations containing gynostemma plant
07/05/2012US20120171284 Celecoxib compositions
07/05/2012US20120171184 Cellular hydration compositions
07/05/2012US20120171151 Mass spectrometric quantitation assay for metabolites of leflunomide
07/05/2012CA2823306A1 Combination of components for the prevention and treatment of frailty
07/04/2012EP2471918A1 Screening method
07/04/2012EP2471916A1 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis
07/04/2012EP2471793A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471791A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471790A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471789A1 Fused heterocyclic ring derivative and use thereof
07/04/2012EP2471786A1 Aminopyrazole derivative
07/04/2012EP2471782A1 Novel sulfonamide derivative and pharmaceutical product containing same
07/04/2012EP2471777A1 Novel tetrahydroisoquinoline compounds
07/04/2012EP2471547A1 Apoptosis inducer
07/04/2012EP2471533A1 Aryl carbonyl derivatives as therapeutic agents
07/04/2012EP2257555B1 Thieno[2,3-d]-pyrimidine-4(3h)-one compounds with antifungal properties and process thereof
07/04/2012EP2062887B1 Aminopyridine derivative having aurora a-selective inhibitory activity
07/04/2012EP1817036B1 Modulators of muscarinic receptors
07/04/2012EP1550662B1 Adenine compound and use thereof
07/04/2012EP1487805B1 Pyrimidine derivatives
07/04/2012EP1485094B1 Dosage form for oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester or its salts
07/04/2012EP1439858B1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
07/04/2012CN1962641B Metalloproteinase inhibitors
07/04/2012CN1907967B Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
07/04/2012CN1845911B Condensed ring compound and use thereof
07/04/2012CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
07/04/2012CN1338939B Compositions for the treatment of male erectile dysfunction
07/04/2012CN102549153A Prophylactic and/or therapeutic agent for metabolic syndrome
07/04/2012CN102548985A Substituted carbonyl compounds
07/04/2012CN102548965A 取代酰胺化合物 Substituted amide compounds
07/04/2012CN102548945A Apogossypolone derivatives as anticancer agents
07/04/2012CN102533640A A method to producing a spheroid population of adult stem cells
07/04/2012CN102532264A Peptide-based compounds
07/04/2012CN102532159A Small molecule inhibitors Syntelin for centromere-associated protein E (CENP-E)
07/04/2012CN102532051A 有丝分裂驱动蛋白抑制剂及其使用方法 Mitotic kinesin inhibitors and methods of use
07/04/2012CN102531995A 3,3'-disubstituted-3-hydroxy bis-indolinone derivative and preparation method and application thereof
07/04/2012CN102531948A 氨基-甲基取代的四环素类化合物 Amino - methyl-substituted tetracycline compounds
07/04/2012CN102526629A Traditional Chinese medicine for treating forehead perspiration symptom
07/04/2012CN102526575A Preparation technology and production method of novel five-flavor decoction integrated dosage form
07/04/2012CN102526496A Traditional Chinese medicine composition for treating fire excess from yin deficiency type sleepless night sweating symptoms, and preparation method of traditional Chinese medicine composition
07/04/2012CN102526352A Medicine for treating pediatric hernia and preparing method thereof
07/04/2012CN102526329A Traditional Chinese medicine for treating night sweat symptom
07/04/2012CN102526215A Extraction technology for removing polygala tenuifolia toxic substances and keeping anti-depressant effective components
07/04/2012CN102526182A Application of Prunella vulgaris Linn. and extract of Prunella vulgaris Linn. to preparation of product for inhibiting angiogenesis
07/04/2012CN102526129A Method for preparing Poria cocos granules by replacing part of auxiliary materials with ultrafine powder
07/04/2012CN102526108A Method for commercial production of bezoar
07/04/2012CN102526094A Medicine for treating swine high fever disease
07/04/2012CN102526045A Methods of increasing endogenous erythropoietin EPO
07/04/2012CN102526044A Methods of increasing endogenous erythropoietin EPO
07/04/2012CN102525910A Process for preparing penehyclidine hydrochloride injection
07/04/2012CN102525909A Method for preparing penehyclidine hydrochloride injection
07/04/2012CN102205071B Chinese medicinal composition for treating thyroid cyst
07/04/2012CN102153650B Anti-EGFR (epidemic growth factor receptor) humanized antibody L2-H3 and coding gene and application thereof
07/04/2012CN102153649B Anti-epidemic growth factor receptor (EGFR) humanized antibody L1-H3 and coded gene and application thereof
07/04/2012CN102153648B EGFR (epidermal growth factor receptor)-inhibiting humanized antibody L4-H3 and encoding genes and application thereof
07/04/2012CN102153647B Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof
07/04/2012CN102091304B Chinese medicine oral liquid with functions of restoring yang qi and dispelling cold and preparation method thereof
07/04/2012CN101898982B Npy y5 antagonists
07/04/2012CN101892189B Transformant for blocking effect of porcine somatostatin by oral immunization and application thereof
07/04/2012CN101816721B Chinese medicinal composition for treating children fever caused by exogenous pathogens and preparation method thereof
07/04/2012CN101654453B Process for the manufacture of the calcium salt of rosuvatatin and crystalline intermediates thereof
07/04/2012CN101574392B Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid
07/04/2012CN101524378B Anti-ageing traditional Chinese medicine preparation
07/04/2012CN101491536B Therapeutically useful synthetic oligonucleotides
07/04/2012CN101401874B Lozenge for refreshing oneself and preparation method thereof
07/04/2012CN101296693B 持久力提高剂 Endurance enhancing agent
07/04/2012CN101259120B Methods of inducing terminal differentiation
07/04/2012CN101209344B Application of hyperosmotic fluid composition in preparing medicament for improving wound healing
07/04/2012CN101115763B Novel polyphenol glycoside derived from acerola
07/04/2012CN101106987B Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
07/04/2012CN101092455B Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
07/03/2012US8212057 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/03/2012US8211945 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
07/03/2012US8211666 Sperm-specific cation channel, CATSPER1, and uses therefor
07/03/2012US8211421 Mutant having uracil phosphoribosyl transferase activity
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2463814C Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 1564